Staff Profile: Irene B. Glowinski

Irene B. Glowinski, Ph.D.

Senior Scientific Program Manager

Division of Clinical Innovation

National Center for Advancing Translational Sciences

National Institutes of Health

Email Irene B. Glowinski


Irene Glowinski is a senior scientific program manager in the Clinical and Translational Science Awards (CTSA) Program within NCATS’ Division of Clinical Innovation (DCI). As a part-time contractor for DCI, she works on the re-competition of CTSAs and co-chairs a committee for Optimize NIH, an initiative to improve the efficiency and effectiveness of internal NIH administrative functions.

Prior to joining NCATS in 2019, Glowinski served for 12 years as the deputy director of the Division of Microbiology and Infectious Diseases (DMID) at the National Institute of Allergy and Infectious Diseases, where she had overall responsibility for strategic planning; for managing, developing, coordinating and evaluating DMID’s extensive portfolio of grants and contracts; and for the budget, policy, legislative and communications activities of the division. From 2000 to 2007, she served as the director of DMID’s Office of Scientific Coordination and Program Operations.

Glowinski started her extramural career at the National Institute of General Medical Sciences, where she served as the assistant chief in the Office of Scientific Review. Previously, she served as deputy director for the Risk Science Institute of the International Life Sciences Institute in Washington, D.C. She also spent two years on Capitol Hill as a Congressional Fellow, working for the U.S. House of Representatives Committee on Science, Space, & Technology. Glowinski retired in March 2019 after 37 years of federal service. She earned her doctorate in pharmacology from the University of Michigan and completed her postdoctoral training in chemical carcinogenesis at the National Cancer Institute.

Professional Interests

Since retirement, Glowinski’s interest has been in increasing the number of undergraduate science majors with an understanding of, and experience in, science policy. She has lectured and currently mentors science students participating in the policy programs at The University of Georgia and University of Michigan.

Selected Publications

  1. NIAID Biodefense Research Agenda for CDC Category A Agents, February 2002
  2. NIAID Biodefense Research Agenda for CDC Category A Agents August 2003 Progress Report
  3. NIAID Biodefense Research Agenda for Category B and C Priority Pathogens. Progress Report, June 2004
  4. NIAID Biodefense Research Agenda for CDC Category A Agents 2006 Progress Report
  5. NIAID Strategic Plan for Biodefense Research 2007 Update